Sphera Funds Management Ltd. Cellectis S.A. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	BUY	$25.99 - $30.6 $2.5 Million - $2.94 Million	96,096 Added 27.31%	447,970 $12.6 Million
Q2 2018 Aug 13, 2018	BUY	$27.78 - $38.53 $347,444 - $481,894	12,507 Added 3.69%	351,874 $9.96 Million
Q4 2017 Feb 12, 2018	SELL	$23.33 - $35.01 $218,578 - $328,008	-9,369 Reduced 2.69%	339,367 $9.89 Million
Q3 2017 Nov 09, 2017	BUY	$21.65 - $32.18 $7.55 Million - $11.2 Million	348,736	348,736 $9.92 Million

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.